Board Meetings for GLENMARK
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| GLENMARK | Glenmark Pharmaceuticals Limited | 30 Jul 2015 | Results | to consider and approve the Company s Unaudited Financial Statements for the First Quarter ended June 30, 2015. | |
| GLENMARK | Glenmark Pharmaceuticals Limited | 29 May 2015 | Results/Dividend | 1. To consider and approve the Company's Audited Financial Statements for the Year ended March 31, 2015. 2. To Consider and recommend dividend, if any, on Equity Shares for the year ended March 31, 2015. | |
| GLENMARK | Glenmark Pharmaceuticals Limited | 12 Feb 2015 | Results | to consider and approve the Company's Unaudited Financial Statements for the Third Quarter ended December 31, 2014. | - |
| GLENMARK | Glenmark Pharmaceuticals Limited | 30 Oct 2014 | Results | To consider and approve the Company's Unaudited Financial Statements for the Second Quarter/Half year ended September 30, 2014. Further, as per the "Code of Conduct for Prevention of Insider Trading" of the Company, the trading window shall remain closed for Directors and other designated employees of the Company from October 17, 2014 to October 31, 2014 (both days inclusive) for the purpose of approval of Unaudited Financial Results for the Second Quarter/Half year ended September 30, 2014. | - |
| GLENMARK | Glenmark Pharmaceuticals Limited | 24 Jul 2014 | Results | To consider and approve the Company's Un-audited Financial Statements for the First Quarter ended June 30, 2014. | |
| GLENMARK | Glenmark Pharmaceuticals Limited | 08 May 2014 | Results/Dividend | 1. To consider and approve the Company's Audited Financial Statements for the Year ended March 31, 2014. 2. To Consider and recommend dividend, if any, on Equity Shares for the year ended March 31, 2014. Further, as per the "Code of Conduct for Prevention of Insider Trading" of the Company, the trading window shall remain closed for Directors and other designated employees of the Company from April 28, 2014 to May 09, 2014 (both days inclusive) for the purpose of approval of Audited Financial Results for the year ended March 31, 2014. | |
| GLENMARK | Glenmark Pharmaceuticals Limited | 24 Jan 2014 | Results | To consider and approve the Company's Un-audited Financial Statements for the Third Quarter ended December 31, 2013. | - |
| GLENMARK | Glenmark Pharmaceuticals Limited | 31 Oct 2013 | Results | to consider and approve the Company's un-audited Financial Statements for the Second Quarter/Half year ended September 30, 2013. | - |
| GLENMARK | Glenmark Pharmaceuticals Limited | 01 Aug 2013 | Results | To consider and approve the Company's Un-audited Financial Statements for the First Quarter ended 30th June, 2013. | - |
| GLENMARK | Glenmark Pharmaceuticals Limited | 07 May 2013 | Results/Dividend | 1. To consider and approve the Company's Audited Financial Statements for the Year ended March 31, 2013. 2. To Consider and recommend dividend, if any, on Equity Shares for the year ended March 31, 2013. | - |
| GLENMARK | Glenmark Pharmaceuticals Limited | 29 Jan 2013 | Un-audited Financial Results | To consider and approve the Company's Unaudited Financial Statements for the Third Quarter ended December 31, 2012. | - |
| GLENMARK | Glenmark Pharmaceuticals Limited | 30 Oct 2012 | Un-audited Financial Results | To consider and approve the Company's Unaudited Financial Statements for the Second Quarter/ Half year ended September 30, 2012. | - |
| GLENMARK | Glenmark Pharmaceuticals Limited | 02 Aug 2012 | Financial Results | To consider and approve the Company's Unaudited Financial Statements for the quarter ended June 30, 2012. | - |
| GLENMARK | Glenmark Pharmaceuticals Limited | 08 May 2012 | Results/Dividend | (1) To consider and approve the Company's Audited Financial Statements for the Year ended March 31, 2012; (2) To consider and recommend dividend, if any, on Equity Shares for the year ended March 31, 2012. | - |
| GLENMARK | Glenmark Pharmaceuticals Limited | 30 Jan 2012 | Un-audited Financial Results | To consider and approve the Un-Audited Financial Results for the third quarter ended December 31, 2011. | - |